WellSpan-THRIVE Cancer QOL Study

Summary

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

Eligibility

Inclusion Criteria:

* Age 18 years and above
* Primary cancer diagnosis (newly diagnosed within the past 6 months)
* Able to sign informed consent.

Exclusion Criteria:

* Patients with age\<18 years,
* Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies.
* Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire.
* Patients with life expectancy of \<90 days, in the opinion of treating investigator.

Conditions7

Locations5 sites

Browse More Trials